Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases.

@article{DashtiKhavidaki2009AdverseRO,
  title={Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases.},
  author={Simin Dashti-Khavidaki and Asghar Aghamohammadi and F Farshadi and Masoud Movahedi and Nima Parvaneh and Nima Pouladi and Kasra Moazzami and Taher Cheraghi and Seyed Alireza Mahdaviani and Shiva Saghafi and Golnaz Heydari and Sina Abdollahzade and Nima Attaran Rezaei},
  journal={Journal of investigational allergology & clinical immunology},
  year={2009},
  volume={19 2},
  pages={139-45}
}
Intravenous immunoglobulin (IVIG) replacement therapy improves health-related quality of life in patients with a primary immunodeficiency disease, although there have been reports of adverse reactions associated with its regular administration. The study population was composed of 99 patients with primary antibody deficiencies. All the patients were diagnosed with a primary immunodeficiency disease and received at least 4 infusions of IVIG at the Children's Medical Center Hospital, Tehran, Iran… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Frequency and clinical

  • N Rezaei, A Aghamohammadi, +21 authors A. Farhoudi
  • J Investig Allergol Clin Immunol
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…